Cargando…

Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes

BACKROUND: Hepatic radiation toxicity restricts irradiation of liver malignancies. Better knowledge of hepatic tolerance dose is favourable to gain higher safety and to optimize radiation regimes in radiotherapy of the liver. In this study we sought to determine the hepatic tolerance dose to small v...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidensticker, Max, Seidensticker, Ricarda, Mohnike, Konrad, Wybranski, Christian, Kalinski, Thomas, Luess, Sebastian, Pech, Maciej, Wust, Peter, Ricke, Jens
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090344/
https://www.ncbi.nlm.nih.gov/pubmed/21496320
http://dx.doi.org/10.1186/1748-717X-6-40
_version_ 1782203141374083072
author Seidensticker, Max
Seidensticker, Ricarda
Mohnike, Konrad
Wybranski, Christian
Kalinski, Thomas
Luess, Sebastian
Pech, Maciej
Wust, Peter
Ricke, Jens
author_facet Seidensticker, Max
Seidensticker, Ricarda
Mohnike, Konrad
Wybranski, Christian
Kalinski, Thomas
Luess, Sebastian
Pech, Maciej
Wust, Peter
Ricke, Jens
author_sort Seidensticker, Max
collection PubMed
description BACKROUND: Hepatic radiation toxicity restricts irradiation of liver malignancies. Better knowledge of hepatic tolerance dose is favourable to gain higher safety and to optimize radiation regimes in radiotherapy of the liver. In this study we sought to determine the hepatic tolerance dose to small volume single fraction high dose rate irradiation. MATERIALS AND METHODS: 23 liver metastases were treated by CT-guided interstitial brachytherapy. MRI was performed 3 days, 6, 12 and 24 weeks after therapy. MR-sequences were conducted with T1-w GRE enhanced by hepatocyte-targeted Gd-EOB-DTPA. All MRI data sets were merged with 3D-dosimetry data. The reviewer indicated the border of hypointensity on T1-w images (loss of hepatocyte function) or hyperintensity on T2-w images (edema). Based on the volume data, a dose-volume-histogram was calculated. We estimated the threshold dose for edema or function loss as the D(90), i.e. the dose achieved in at least 90% of the pseudolesion volume. RESULTS: At six weeks post brachytherapy, the hepatocyte function loss reached its maximum extending to the former 9.4Gy isosurface in median (i.e., ≥9.4Gy dose exposure led to hepatocyte dysfunction). After 12 and 24 weeks, the dysfunctional volume had decreased significantly to a median of 11.4Gy and 14Gy isosurface, respectively, as a result of repair mechanisms. Development of edema was maximal at six weeks post brachytherapy (9.2Gy isosurface in median), and regeneration led to a decrease of the isosurface to a median of 11.3Gy between 6 and 12 weeks. The dose exposure leading to hepatocyte dysfunction was not significantly different from the dose provoking edema. CONCLUSION: Hepatic injury peaked 6 weeks after small volume irradiation. Ongoing repair was observed up to 6 months. Individual dose sensitivity may differ as demonstrated by a relatively high standard deviation of threshold values in our own as well as all other published data.
format Text
id pubmed-3090344
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30903442011-05-10 Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes Seidensticker, Max Seidensticker, Ricarda Mohnike, Konrad Wybranski, Christian Kalinski, Thomas Luess, Sebastian Pech, Maciej Wust, Peter Ricke, Jens Radiat Oncol Research BACKROUND: Hepatic radiation toxicity restricts irradiation of liver malignancies. Better knowledge of hepatic tolerance dose is favourable to gain higher safety and to optimize radiation regimes in radiotherapy of the liver. In this study we sought to determine the hepatic tolerance dose to small volume single fraction high dose rate irradiation. MATERIALS AND METHODS: 23 liver metastases were treated by CT-guided interstitial brachytherapy. MRI was performed 3 days, 6, 12 and 24 weeks after therapy. MR-sequences were conducted with T1-w GRE enhanced by hepatocyte-targeted Gd-EOB-DTPA. All MRI data sets were merged with 3D-dosimetry data. The reviewer indicated the border of hypointensity on T1-w images (loss of hepatocyte function) or hyperintensity on T2-w images (edema). Based on the volume data, a dose-volume-histogram was calculated. We estimated the threshold dose for edema or function loss as the D(90), i.e. the dose achieved in at least 90% of the pseudolesion volume. RESULTS: At six weeks post brachytherapy, the hepatocyte function loss reached its maximum extending to the former 9.4Gy isosurface in median (i.e., ≥9.4Gy dose exposure led to hepatocyte dysfunction). After 12 and 24 weeks, the dysfunctional volume had decreased significantly to a median of 11.4Gy and 14Gy isosurface, respectively, as a result of repair mechanisms. Development of edema was maximal at six weeks post brachytherapy (9.2Gy isosurface in median), and regeneration led to a decrease of the isosurface to a median of 11.3Gy between 6 and 12 weeks. The dose exposure leading to hepatocyte dysfunction was not significantly different from the dose provoking edema. CONCLUSION: Hepatic injury peaked 6 weeks after small volume irradiation. Ongoing repair was observed up to 6 months. Individual dose sensitivity may differ as demonstrated by a relatively high standard deviation of threshold values in our own as well as all other published data. BioMed Central 2011-04-17 /pmc/articles/PMC3090344/ /pubmed/21496320 http://dx.doi.org/10.1186/1748-717X-6-40 Text en Copyright ©2011 Seidensticker et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Seidensticker, Max
Seidensticker, Ricarda
Mohnike, Konrad
Wybranski, Christian
Kalinski, Thomas
Luess, Sebastian
Pech, Maciej
Wust, Peter
Ricke, Jens
Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes
title Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes
title_full Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes
title_fullStr Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes
title_full_unstemmed Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes
title_short Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes
title_sort quantitative in vivo assessment of radiation injury of the liver using gd-eob-dtpa enhanced mri: tolerance dose of small liver volumes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090344/
https://www.ncbi.nlm.nih.gov/pubmed/21496320
http://dx.doi.org/10.1186/1748-717X-6-40
work_keys_str_mv AT seidenstickermax quantitativeinvivoassessmentofradiationinjuryoftheliverusinggdeobdtpaenhancedmritolerancedoseofsmalllivervolumes
AT seidenstickerricarda quantitativeinvivoassessmentofradiationinjuryoftheliverusinggdeobdtpaenhancedmritolerancedoseofsmalllivervolumes
AT mohnikekonrad quantitativeinvivoassessmentofradiationinjuryoftheliverusinggdeobdtpaenhancedmritolerancedoseofsmalllivervolumes
AT wybranskichristian quantitativeinvivoassessmentofradiationinjuryoftheliverusinggdeobdtpaenhancedmritolerancedoseofsmalllivervolumes
AT kalinskithomas quantitativeinvivoassessmentofradiationinjuryoftheliverusinggdeobdtpaenhancedmritolerancedoseofsmalllivervolumes
AT luesssebastian quantitativeinvivoassessmentofradiationinjuryoftheliverusinggdeobdtpaenhancedmritolerancedoseofsmalllivervolumes
AT pechmaciej quantitativeinvivoassessmentofradiationinjuryoftheliverusinggdeobdtpaenhancedmritolerancedoseofsmalllivervolumes
AT wustpeter quantitativeinvivoassessmentofradiationinjuryoftheliverusinggdeobdtpaenhancedmritolerancedoseofsmalllivervolumes
AT rickejens quantitativeinvivoassessmentofradiationinjuryoftheliverusinggdeobdtpaenhancedmritolerancedoseofsmalllivervolumes